Profile
Phillip Altman is the founder of Pharmaco Pty Ltd., ARCS Australia Ltd.
He worked as a Non-Executive Director at Viralytics Pty Ltd.
from 2009 to 2014.
Altman received his undergraduate, graduate, and doctorate degrees from The University of Sydney.
Phillip Altman active positions
| Companies | Position | Start |
|---|---|---|
| ARCS Australia Ltd. | Founder | 10/12/2010 |
Former positions of Phillip Altman
| Companies | Position | End |
|---|---|---|
| VIRALYTICS LTD. | Director/Board Member | 01/09/2014 |
| Pharmaco Pty Ltd. | Founder | - |
Training of Phillip Altman
| The University of Sydney | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
| Pharmaco Pty Ltd. | |
| ARCS Australia Ltd. |
- Stock Market
- Insiders
- Phillip Altman
